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Abstract 
Background: The inflammatory response plays a key role at different stages of cancer development. Allelic vari‑
ants of the interleukin 1A (IL1A), interleukin 4 (IL4), nuclear factor kappa B1 (NFKB1) and protease‑activated receptor 
1 (PAR1) genes may influence not only the inflammatory response but also susceptibility to cancer development. 
Among major ethnic or continental groups, these polymorphic variants present different allelic frequencies. In 
admixed populations, such as the Brazilian population, data on distribution of these polymorphisms are limited. Here, 
we collected samples of cancer‑free individuals from the north, northeast, midwest, south and southeast regions of 
Brazil and from the three main groups that gave rise to the Brazilian population: Native Americans from the Brazilian 
Amazon, Africans and Europeans. We describe the allelic distributions of four IL1A (rs3783553), IL4 (rs79071878), NFKB1 
(rs28362491) and PAR1 (rs11267092) gene polymorphisms, which the literature describes as polymorphisms with a risk 
of cancer or worse prognosis for cancer.
Results: The genotypic distribution of the four polymorphisms was statistically distinct between Native Americans, 
Africans and Europeans. For the allelic frequency of these polymorphisms, the Native American population was the 
most distinct among the three parental populations, and it included the greatest number of alleles with a risk of 
cancer or worse prognosis for cancer. The PAR1 gene polymorphism allelic distribution was similar among all Brazil‑
ian regions. For the other three markers, the northern region population was statistically distinct from other Brazilian 
region populations.
Conclusion: The IL1A, IL4, NFKB1 and PAR1 gene polymorphism allelic distributions are homogeneous among the 
regional Brazilian populations, except for the northern region, which significantly differs from the other four Brazilian 
regions. Among the parental populations, the Native American population exhibited a higher incidence of alleles with 
risk of cancer or worse prognosis for cancer, which can indicate greater susceptibility to this disease. These genetic 
data may be useful for future studies on the association between these polymorphisms and cancer in the investi‑
gated populations.
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Background
External factors that modify tissue homeostasis, such as 
microorganism infection, tissue injury and exposure to 
contaminants may induce inflammatory processes [1]. 
Chronic inflammation is associated with the appearance 
of malignant cells and these cells’ proliferation, invasion 
and metastasis processes [2].
The inflammatory response may be modulated through 
gene expression variations due to structural genetic pol-
ymorphisms or regulatory regions. Therefore, an indi-
vidual genetic composition may influence not only the 
inflammatory response but also susceptibility to cancer 
development [3, 4].
Recently, many studies have tested the association 
between different forms of cancer and functional variants 
of genes responsible for the inflammatory process [5–8], 
such as interleukin 1A (IL1A), interleukin 4 (IL4), nuclear 
factor kappa B1 (NFKB1) and protease-activated receptor 
1 (PAR1) [9–12].
The gene for the pro-inflammatory cytokine IL1A 
presents an insertion/deletion (INDEL) polymorphism 
(3′UTR indel TTCA, rs3783553) in a binding site for 
the microRNAs miR-122 and miR-378 that modifies the 
connection between these microRNAs. The insertion 
(Ins) allele is related to higher gene expression [13]. Dif-
ferent investigations have demonstrated that individuals 
homozygous for the insertion (Ins/Ins) are less suscepti-
ble to developing gastric cancer, nasopharyngeal cancer, 
hepatocellular carcinoma and cervical cancer [13–16].
Interleukin-4 (IL4), which is an anti-inflammatory 
cytokine gene, presents a VNTR polymorphism (intron 3 
VNTR—70 bp, rs79071878) located on the third intron. 
Different alleles for this polymorphism modulate gene 
expression. The allele with two repeats (A2) is related to 
higher gene expression, while the allele with three repeats 
(A3) is related to lower expression [17, 18]. A homozy-
gous genotype for higher IL4 expression (A2/A2) is asso-
ciated with a worse prognosis in bladder cancer patients 
and with oral and pharyngeal cancers [19, 20].
Transcription factor NFKB1 plays an important role 
in the inflammatory process, and it can influence can-
cer development and aggressiveness, increasing tumour 
angiogenesis and repressing the immune response [21]. 
The NFKB1 gene carries an INDEL polymorphism in 
the promoter region (−94 indel ATTG, rs28362491) that 
exerts a regulatory effect on gene expression. The inser-
tion allele is associated with an increase in promoter 
activity and protein synthesis [22].
Several studies on the association between rs28362491 
and the risk of developing cancer show conflicting results 
[9, 23–25]. In a recent meta-analysis of 21 case–control 
studies, Yang et  al. [21] showed that the insertion allele 
for this polymorphism is significantly associated with a 
risk of developing oral, prostate and ovary cancers. The 
analyses also reveal similar results in Asian populations, 
but not in European populations, which suggests ethnic 
variations in predisposition to different types of cancer.
The receptor PAR1 is a member of the superfam-
ily of G protein-coupled membrane receptors [26]. 
These receptors regulate processes ranging from vas-
cular integrity to systemic inflammation. Activation of 
the PAR1 receptor in epithelial cells, macrophages and 
endothelial cells promotes the release of pro-inflamma-
tory mediators, such as TNF, IL1β, IL2, IL6, CXCL8 and 
CCL2 [27]. The PAR1 gene features an INDEL polymor-
phism (−506 indel—13  bp, rs11267092) located in the 
promoter region [28]. The deletion allele (Del) is related 
to a better prognosis in breast, stomach and oesophagus 
cancers [29–31].
The polymorphisms described above exhibit common 
features. (1) They are functional polymorphisms that 
alter the expression of genes that participate in and for 
metabolic pathways associated with carcinogenesis. (2) 
Such genes are associated with different types of cancer 
with high incidence in the Brazilian population, espe-
cially prostate, stomach, oesophagus, breast and cervical 
cancers [32]. (3) The genes vary in populations with dif-
ferent ethnic and geographic origins [33]. (4) Information 
on allele distributions in Native Americans and admixed 
populations, such as the Brazilian population, is limited. 
(5) From a technical perspective, all of the investigated 
polymorphisms are small INDELs; therefore, genotyping 
may be performed using a single PCR step followed by 
capillary electrophoresis, which is an accessible and low-
cost laboratory technique.
The Brazilian population is one of the most hetero-
geneous populations worldwide that is formed by an 
admixture of Native Americans, Europeans and Africans. 
This heterogeneity has been well-documented in several 
genetic investigations [34–39]. The admixture process 
occurred through different means between the Brazil-
ian geographic regions. Therefore, the Native American 
contribution is more pronounced in Northern Brazil; 
the African contribution is more elevated in Northeast 
Brazil; and the South features a European predominance 
with little Native American and African influence [39].
We must know the distribution of allelic frequen-
cies of these polymorphisms [IL-1A (rs3783553), 
IL4 (rs79071878), NFKB1 (rs28362491) and PAR1 
(rs11267092)] for association studies on cancer, data for 
which is limited on Brazilian populations. Thus, the aim 
of this study is to characterize allelic distributions in a 
representative sample of the Brazilian population from all 
geographic regions of the country.
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Results
The allele and genotype frequencies of the investigated 
polymorphisms (rs3783553, rs79071878, rs28362491 
and rs11267092) in samples from the five Brazilian geo-
graphic regions and in the parental populations are pre-
sented in Table  1. The genotypic distributions of the 
markers exhibited a Hardy–Weinberg equilibrium in 
the investigated populations, except for the NFKB1 gene 
marker in the European sample (p = 0.003).
When we compared allelic distributions in parental 
populations, all markers exhibited a significantly differ-
ent allele frequency between the three groups, and the 
Native American populations exhibited more differences 
from the continental populations (Table  2). Among the 
four markers, the average frequency difference (value δ) 
between the Native Americans and Africans was 34  %; 
between the Native Americans and Europeans was 37 %; 
and between the Europeans and Africans was 20  %. 
When we considered each marker individually, a higher 
average frequency difference was observed between the 
continents for IL1A (40 %) followed by IL4 (34 %), PAR1 
(30 %) and NFKB1 (17 %).
For the geographic region comparisons (Table  2), 
rs11267092 (PAR1 gene) showed no significant difference 
between the Brazilian regions. The distributions of the 
other three polymorphisms (rs3783553, rs79071878 and 
rs28362491) were statistically similar between the north-
east, south and southeast regions.
The analyses showed statistically significant differ-
ences in the rs3783553, rs79071878 and rs28362491 
polymorphism distributions between the northern pop-
ulation and the populations in the other regions, except 
the rs3783553 polymorphism in the midwest region 
(p = 0.543). This polymorphism exhibited a significantly 
different distribution in the midwest population com-
pared with the northeast, south and southeast regions.




















180 187 186 184 191 222 211 268
Ins/Ins 52 (28.9) 89 (47.6) 57 (30.6) 91 (49.5) 102 (53.4) 08 (13.5) 129 (61.1) 132 (33.7)
Ins/Del 92 (51.1) 77 (41.2) 100 (53.8) 74 (40.2) 70 (36.6) 65 (45.5) 71 (33.7) 111 (55.9)
Del/Del 36 (20.0) 21 (11.2) 29 (15.6) 19 (10.3) 19 (10.0) 149 (41.0) 11 (5.2) 25 (10.4)
Ins 0.545 0.682 0.575 0.696 0.717 0.182 0.780 0.700
Del 0.455 0.318 0.425 0.304 0.283 0.818 0.220 0.300
IL4
(rs79071878)
180 187 186 184 191 222 211 268
A3/A3 61 (33.9) 109 (58.3) 104 (55.9) 98 (53.3) 114 (60.0) 12 (5.4) 22 (10.4) 143 (53.3)
A3/A2 89 (49.4) 72 (38.5) 70 (37.6) 78 (42.4) 69 (36.3) 77 (34.7) 133 (63.0) 109 (40.7)
A2/A2 30 (16.7) 06 (3.2) 12 (6.5) 08 (4.3) 07 (3.7) 133 (59.9) 56 (26.6) 16 (6.0)
A3 0.586 0.775 0.747 0.745 0.782 0.227 0.420 0.737
A2 0.414 0.225 0.253 0.255 0.218 0.773 0.580 0.263
NFKB1
(rs28362491)
180 187 185 184 191 222 211 268
Ins/Ins 34 (18.9) 75 (40.0) 62 (33.5) 61 (33.2) 73 (38.2) 30 (13.5) 47 (22.3) 90 (33.6)
Ins/Del 99 (55.0) 80 (43.0) 88 (47.6) 88 (47.8) 93 (48.7) 101 (45.5) 109 (51.7) 151 (56.3)
Del/Del 47 (26.1) 32 (17.0) 35 (18.9) 35 (19.0) 25 (13.1) 91 (41.0) 55 (26.0) 27 (10.1)
Ins 0.464 0.615 0.573 0.571 0.626 0.363 0.481 0.617
Del 0.536 0.385 0.427 0.429 0.374 0.637 0.519 0.383
PAR1
(rs11267092)
180 187 186 183 191 222 199 267
Ins/Ins 11 (6.1) 17 (9.1) 18 (9.8) 22 (12.0) 16 (8.4) 02 (0.9) 56 (28.1) 12 (4.5)
Ins/Del 56 (31.1) 76 (40.6) 67 (36.0) 64 (35.0) 61 (31.9) 17 (7.7) 86 (43.2) 98 (36.7)
Del/Del 113 (62.8) 94 (50.3) 101 (54.3) 97 (53.0) 114 (59.7) 203 (91.4) 57 (28.7) 157 (58.8)
Ins 0.217 0.294 0.277 0.295 0.243 0.047 0.497 0.228
Del 0.783 0.706 0.723 0.705 0.757 0.953 0.503 0.772
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All polymorphisms investigated here have been pre-
viously described as associated with a predisposition to 
some form of cancer [14, 15, 21, 24, 25], as well as com-
pared with the prognosis of the disease [19, 29–31]. We 
proposed a different approach to analysing the popula-
tion data. Under this new approach, the proportion of 
individuals who are allele carriers are considered at risk 
for cancer or worse prognosis for cancer (referred to as 
potentially deleterious alleles [40]), including the deletion 
allele for rs3783553, allele A2 for rs79071878, the inser-
tion allele for rs28362491, and the insertion allele for 
rs11267092.
Based on this analysis, the proportion of potentially 
deleterious alleles is higher in the Native American 
population (50 %) than the African (44 %) and European 
(35 %) populations. Among Brazilians, the proportion of 
potentially deleterious alleles is 40 %. Likewise, the pro-
portion of individuals who are carriers of six or more 
alleles associated with cancer is greater among the Native 
Americans (8.6  %) than the Africans (5.2  %) and Euro-
peans (1.9 %), and the proportion of Brazilians (4.2 %) is 
intermediate among the ancestral population values. The 
proportion of carriers is not evenly distributed between 
the geographic regions. The proportion is smaller in the 
Northeast Brazil population (2.7 %), intermediate in Mid-
west and South Brazil populations (mean =  3.4  %) and 
more elevated in the North (5.0 %) and Southeast Brazil 
populations (6.5 %).
Discussion
This is the most comprehensive study on the rs3783553, 
rs79071878, rs28362491 and rs11267092 polymorphism 
variations in Brazil and among its ancestral populations. 
This is also the first study to describe the variability of 
these markers in Native American populations.
We evaluated the distribution of allele and genotype 
frequencies for these four markers among the pairs of 
ancestral and Brazilian populations using the Chi-square 
test with the due statistical corrections (false discovery 
rate) to avoid spurious correlations. This test is adequate 
to compare two or more populations for a qualitative 
variable [41]. Furthermore, our sample size is representa-
tive of the populations studied here (928 Brazilians, 222 
Native Americans, 211 Africans and 268 Europeans) and 
adequate for using INDEL-type polymorphisms, which 
present a low mutation rate compared with other types of 
polymorphisms [42].
The data from the ancestral populations investigated 
here reveal considerable heterogeneity between con-
tinental populations. All investigated markers present 
δ values greater than 30  %, except for the NFKB1 gene 
polymorphism. In this set of markers, the Native Ameri-
can populations were the most differentiated among the 
investigated continental populations.
Given the differences in the observed allelic distribu-
tion between the parental populations, we tested the 
hypothesis that these differences were due to popula-
tion sampling. Therefore, we used data published in the 
1000 Genomes project (Table  3). We verified that the 
cited frequency for the IL1A, NFKB1 and PAR1 mark-
ers (the three markers for which data were available) 
in the African and European populations are similar 
to the frequency observed herein. Thus, we discard the 
hypothesis and assume that our samples are representa-
tive of the European, African and Native American 
populations.
Table 2 Comparison of  the genotypic distribution of  polymorphisms in  IL1A, IL4, NFKB1 and  PAR1 genes between  the 
studied populations
* All p values were corrected by FDR method
Populations IL1A (rs3783553) IL4 (rs79071878) NFKB1 (rs28362491) PAR1 (rs11267092)
χ2 (df = 2) p value* χ2 (df = 2) p value* χ2 (df = 2) p value* χ2 (df = 2) p value*
Native Americans × Africans 216.025 <0.0001 54.614 <0.0001 12.663 0.0018 177.78 <0.0001
Native Americans × Europeans 207.731 <0.0001 205.587 <0.0001 70.009 <0.0001 66.495 <0.0001
Africans × Europeans 7.595 0.0224 71.667 <0.0001 22.701 <0.0001 67.497 <0.0001
North × Northeast 14.860 0.0006 31.226 <0.0001 19.925 0.0001 5.929 0.0516
North × Midwest 1.219 0.5438 21.098 <0.0001 13.136 0.0014 3.249 0.197
North × Southeast 17.801 0.0001 22.03 <0.0001 10.858 0.0044 5.287 0.0711
North × South 24.171 <0.0001 33.100 <0.0001 20.701 <0.0001 0.819 0.6641
Northeast × Midwest 11.280 0.0036 2.143 0.3435 1.085 0.5814 0.844 0.6559
Northeast × Southeast 0.158 0.4292 1.086 0.5810 1.651 0.4380 1.837 0.3992
Northeast × South 1.276 0.5284 0.259 0.8785 1.821 0.4022 3.554 0.1692
Midwest × Southeast 13.769 0.001 1.4 0.4966 0.129 0.9376 0.56 0.7556
Midwest × South 20.051 <0.0001 1.810 0.4046 1.366 0.5051 1.119 0.5715
Southeast × South 0.608 0.738 1.844 0.3976 2.277 0.3202 2.133 0.3441
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Despite the frequency differences between the parental 
populations and the intense and heterogeneous process 
of admixture that formed the current Brazilian popula-
tion, the allelic distribution is relatively homogeneous 
throughout most of the country. In general, only the 
northern population exhibits an allele distribution that 
significantly differs from the other geographic regions for 
three of the four investigated markers.
We understand that these differences may be explained 
by a greater contribution of Native Americans to the 
northern populations. Previous estimates using different 
types of genetic markers show that the greatest Native 
American genetic contribution among Brazilians occurs 
in North populations [36, 38, 39, 43]. Moreover, data gen-
erated in the present work show that Native Americans 
form the most differentiated group of all the continental 
populations that form the Brazilian population. There-
fore, we believe that, conjunctively, these two factors may 
explain the observed differentiation in the Northern Bra-
zil population.
Our analyses involving potentially deleterious alleles 
demonstrate that the Native American population pre-
sents a higher proportion (50  %) of these alleles com-
pared with the other parental populations (44 and 35 % 
for African and European, respectively). This analysis 
holds when considering the proportion of carriers with 
six or more (among eight possible) potentially deleterious 
alleles.
However, we cannot evaluate how this genetic com-
position may be associated with a higher incidence of 
cancer in this population because Native American 
populations form traditional communities that reside in 
outlying areas of urban centres. Epidemiological data are 
not available on the incidence of different types of cancer 
among these populations.
Despite the absence of epidemiological data, recent 
studies demonstrate that different forms of cancer are 
associated with a higher (or lower) contribution from 
Native American ancestry in admixed populations from 
South America. The investigations were associated with 
acute lymphoblastic leukaemia [44], breast cancer [45] 
and gastric cancer [45–47].
Conclusion
In summary, our study shows that the allelic distribu-
tion of the IL-1A (rs3783553), IL4 (rs79071878), NFKB1 
(rs28362491) and PAR1 (rs11267092) gene polymor-
phisms differs between European, African and Native 
American populations. Further, the same heterogeneity 
is not observed between regional populations in Brazil, 
except for the northern region, which significantly differs 
from the other four Brazilian regions.
Moreover, the results show that the Native American 
population includes a greater proportion of carriers with 
six or more alleles associated with cancer, which suggests 
that this population may have a higher risk of developing 
(or worse prognosis for) diseases associated with these 
alleles. The presented genetic data may be useful for 
future studies on the association between these polymor-
phisms and cancer in these populations.
Methods
Study population
The study population consists of 928 non-related and 
cancer-free adult individuals, recruited in ten Brazil-
ian Federal Units, between the years of 2009 and 2010. 
In the present work, 180 individuals (90 male and 90 
female) residing in the states of Pará (60), Amazonas 
(60) and Rondônia (60) represented the North region; 
187 individuals (107 male and 80 female) residing in the 
states of Ceará (135) and Pernambuco (52) represented 
the Northeast region; 186 individuals (95 male and 91 
female) residing in the states of Goiás (101), Mato Grosso 
do Sul (49) and Distrito Federal (36) represented the 
Midwest region; 184 individuals (90 male and 94 female) 
residing in the state of São Paulo represented the South-
east region; and 191 individuals (96 male and 95 female) 
residing in the state of Rio Grande do Sul represented the 
Table 3 Frequencies of the deletion allele in the polymorphisms of the IL1A, IL4, NFKB1 and PAR1 genes in Brazil and in 
other world populations
Populations Number of Chromosomes References IL1A IL4 (A2) NFKB1 PAR1
Brazil 1848 This study 0.358 0.273 0.426 0.737
Native Americans 444 This study 0.818 0.773 0.637 0.953
Africans 422 This study 0.220 0.580 0.519 0.503
Europeans 536 This study 0.300 0.263 0.383 0.771
Africans 2184 1000 Genomes [33] 0.230 – 0.530 –
African Americans 2184 1000 Genomes [33] – – – 0.500
Europeans 2184 1000 Genomes [33] 0.330 – 0.410 0.750
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South region. Additional details may be found in a previ-
ous study [48].
In addition, we investigated a sample of 701 individu-
als representative of the main ethnic groups that origi-
nated the Brazilian population: 222 Native Americans 
from nine tribes of the Brazilian Amazon (Tiriyó, Waiãpi, 
Zoé, Urubu-Kaapor, Awa-Guajá, Parakanã, Wai Wai, 
Gavião, Zoró) [49]; 211 Africans (Angola, Mozambique, 
Congo Republic, Cameroon, Ivory Coast) [50]; and 268 
Europeans (all from Portugal and Spain) that have been 
commonly studied in previous investigations on Brazilian 
ancestry [37, 39].
Informed consent for DNA analysis was obtained 
from healthy individuals for research purposes. Ethics 
approval was obtained from the local committee of Insti-
tuto de Ciências da Saúde, Universidade Federal do Pará.
Genotyping of investigated polymorphisms
Four polymorphisms were genotyped by a single multi-
plex reaction with Master Mix QIAGEN® Multiplex PCR 
kit (Qiagen, Hilden, Germany) and the primers described 
in Table 4.
Multiplex PCR products were separated and analyzed 
by capillary electrophoresis on the ABI 3130 Genetic 
Analyzer instrument (Applied Biosystems), using GS-500 
LIX as pattern of molecular weight (Applied Biosystems), 
G5 virtual filter matrix and POP7 (Applied Biosystems). 
After data collect, samples were analyzed in GeneMap-
per®3.7 software (Applied Biosystems).
Statistical analyses
Allelic and genotypic frequencies were obtained by direct 
counting and δ value (delta value) was determined by 
substracting values of allele frequency in the studied 
parental populations, as described by Santos et  al. [39]. 
Hardy–Weinberg equilibrium deviations were tested in 
Arlequin 3.1 software [51]. Differences in genotypic fre-
quencies between Brazilian regions and parental popula-
tions were measured by Chi-square test (χ2 test, df = 2) 
in BioEstat software [52]. FDR (False Discovery Rate) 
method was used to correct multiple analyses [53]. These 
analyses were performed in the statistical package R Cal-
culation. P value was considered significant if lower than 
0.05.
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